Erlangen, Germany | Aug 02, 2020
Siemens Healthineers AG today announced its results for the third quarter of fiscal year 2020 that ended June 30, 2020.
Q3 Fiscal Year 2020
- Revenue down 6.9% year-over-year on a comparable basis due to COVID-19
- Comparable revenue decline of 3.3% in Imaging, Advanced Therapies with comparable decline of 1.8%
- Service with slight comparable revenue growth, stabilizing business
- Equipment book-to-bill ratio at 0.94
- Diagnostics with comp. revenue decline of 15.9% due to lower testing for routine care, significantly impacting profitability
- Adjusted EBIT margin at 13.9%, 120 bps below prior-year quarter
- Adjusted basic earnings per share down 21% to €0.30
- Q3 free cash flow increases 48% year-over-year to €336 million
- Comparable revenue growth expected to be broadly flat in fiscal year 2020; adjusted basic earnings per share expected to be between €1.54 and €1.62. This is based on the assumption that the current business environment will not deteriorate again
Bernd Montag, CEO of Siemens Healthineers AG:
“The Siemens Healthineers team has been making an extraordinary contribution to overcoming this historic crisis for months – at our customers’ sites, in production, at our locations around the world and through rapid innovation. The development in the third quarter underscores the resilience of our business. For the fourth quarter, we are anticipating a significant improvement of our business performance compared to the third quarter.”
ADVERTISEMENT
